| Recruiting | Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder NCT07072728 | Psyence Australia Pty Ltd | Phase 2 |
| Recruiting | Investigation of Three Biomarkers for the Detection of Prostate Cancer NCT06554587 | Medtechtomarket Consulting Ltd | — |
| Recruiting | The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Pr NCT06406803 | Maastricht University Medical Center | N/A |
| Recruiting | Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer NCT04887935 | Washington University School of Medicine | Phase 1 |
| Recruiting | Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Can NCT05600400 | Sunnybrook Health Sciences Centre | N/A |
| Recruiting | ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prosta NCT05653063 | University College, London | — |
| Recruiting | A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combinatio NCT05361798 | National Cancer Institute (NCI) | Phase 2 |
| Enrolling By Invitation | Real-time Motion Management During Prostate and Lung Radiotherapy NCT05844761 | Region Skane | N/A |
| Withdrawn | Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC NCT05191017 | Nuvation Bio Inc. | Phase 1 / Phase 2 |
| Recruiting | Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention NCT06318559 | Fondazione del Piemonte per l'Oncologia | N/A |
| Terminated | NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid NCT05252390 | Nuvation Bio Inc. | Phase 1 |
| Recruiting | A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors NCT05214937 | University of Toronto | N/A |
| Unknown | Retzius-sparing Technique in Robotic-assisted Radical Prostatectomy NCT05224024 | Ankara University | N/A |
| Active Not Recruiting | Onco-primary Care Networking to Support TEAM-based Care NCT04258813 | Duke University | N/A |
| Active Not Recruiting | Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA NCT04319783 | Trans Tasman Radiation Oncology Group | Phase 2 |
| Recruiting | A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive a NCT04633252 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors NCT04541225 | Nuvation Bio Inc. | Phase 1 |
| Completed | Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgramme NCT04304196 | St. Mary's Research Center, Canada | N/A |
| Terminated | Hypertension Management in Cancer Patients NCT03919214 | Duke University | N/A |
| Unknown | Radiotherapy Combined With a LHRH (Ant)Agonist Versus Apalutamide in Patients With Biochemical Recurrence Afte NCT03899077 | Cancer Research Antwerp | Phase 2 |
| Unknown | The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958 | SpeciCare | — |
| Completed | De-implementation of Low Value Castration for Men With Prostate Cancer NCT03579680 | University of Michigan | N/A |
| Completed | Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia NCT03444532 | Danish Cancer Society | N/A |
| Recruiting | Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer NCT03354416 | National Cancer Institute (NCI) | — |
| Completed | Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy NCT03388619 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX®) in Patients With Prostate Cancer NCT03450109 | Luye Pharma Group Ltd. | Phase 1 |
| Enrolling By Invitation | 18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer NCT03181867 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Bi NCT03442075 | Instituto Mexicano del Seguro Social | — |
| Completed | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) NCT03133286 | DxTerity Diagnostics | — |
| Completed | Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI) NCT03031418 | Exosome Diagnostics, Inc. | — |
| Completed | Optimizing the Effectiveness of Routine Post-treatment Surveillance in Prostate Cancer Survivors NCT02957357 | Alliance Foundation Trials, LLC. | — |
| Completed | Bicalutamide With or Without Metformin for Biochemical Recurrence in Overweight or Obese Prostate Cancer Patie NCT02614859 | Fox Chase Cancer Center | Phase 2 |
| Completed | Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previou NCT02362464 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Prostatic Cancer Versus Androgen Deficiency NCT02235142 | Hopital Foch | N/A |
| Completed | Sipuleucel-T Manufacturing Demonstration Study NCT01477749 | Dendreon | Phase 2 |
| Completed | Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci NCT01639859 | Hospices Civils de Lyon | N/A |
| Unknown | Dynamic Focusing Evaluation for Prostate Cancer Treatment NCT03632980 | EDAP TMS S.A. | N/A |
| Completed | North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS) NCT02564120 | UNC Lineberger Comprehensive Cancer Center | — |
| Terminated | Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy Simulator NCT00999960 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Abl NCT00970203 | Roswell Park Cancer Institute | Phase 2 |
| Recruiting | Collection of Blood From Patients With Prostate Cancer NCT00923221 | National Cancer Institute (NCI) | — |
| Completed | A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Sw NCT00220194 | San Bernardino Urological Associates Medical Group Inc | Phase 4 |
| Completed | A Study for the Treatment of Hormone Refractory Prostate Cancer (HRPC) in Patients Previously Treated With Che NCT00257478 | Astellas Pharma Inc | Phase 2 |